Literature DB >> 3653199

Changes in testicular cancer in Scotland.

P Boyle1, S B Kaye, A G Robertson.   

Abstract

There are two purposes to this paper. Firstly to describe the temporal pattern of germ-cell testicular cancers in Scotland, both as a single entity and as the histological sub-types (pure) seminoma and teratoma. Incidence rates rose by over 50% between 1959 and 1984, with the rates of seminoma increasing only marginally and the majority of the overall increase accounted for by the substantial increase observed among the sub-type teratoma. Secondly, to investigate the impact of new therapies on the mortality rate from germ-cell testicular cancer in Scotland in the light of improvements in survival rate reported during the last 25 years from clinical trials and clinical series. Noticeable changes have occurred in the temporal pattern of mortality which cannot be explained by changes in incidence. The ever-widening gap between the increasing incidence rate and the declining mortality rate, particularly apparent in the high-risk age group 15-44, indicates an improving prognosis for patients with this malignancy in Scotland.

Entities:  

Mesh:

Year:  1987        PMID: 3653199     DOI: 10.1016/0277-5379(87)90286-0

Source DB:  PubMed          Journal:  Eur J Cancer Clin Oncol        ISSN: 0277-5379


  14 in total

Review 1.  Evidence for decreasing quality of semen during past 50 years.

Authors:  E Carlsen; A Giwercman; N Keiding; N E Skakkebaek
Journal:  BMJ       Date:  1992-09-12

2.  Retroperitoneal lymph node dissection for metastatic germ cell tumours.

Authors:  N Haldipur; S Devaraj; A Shehata; A K Lewis; M O Smith; M Hatton; A Nassef; J D Beard
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

3.  Evidence of deteriorating semen quality in the United Kingdom: birth cohort study in 577 men in Scotland over 11 years.

Authors:  S Irvine; E Cawood; D Richardson; E MacDonald; J Aitken
Journal:  BMJ       Date:  1996-02-24

Review 4.  Male reproductive health and environmental xenoestrogens.

Authors:  J Toppari; J C Larsen; P Christiansen; A Giwercman; P Grandjean; L J Guillette; B Jégou; T K Jensen; P Jouannet; N Keiding; H Leffers; J A McLachlan; O Meyer; J Müller; E Rajpert-De Meyts; T Scheike; R Sharpe; J Sumpter; N E Skakkebaek
Journal:  Environ Health Perspect       Date:  1996-08       Impact factor: 9.031

5.  Trends in the incidence of testicular germ cell cancer in Ontario by histologic subgroup, 1964-1996.

Authors:  H K Weir; L D Marrett; V Moravan
Journal:  CMAJ       Date:  1999-01-26       Impact factor: 8.262

6.  Aetiology of testicular cancer: association with congenital abnormalities, age at puberty, infertility, and exercise. United Kingdom Testicular Cancer Study Group.

Authors: 
Journal:  BMJ       Date:  1994-05-28

7.  Developmental exposure to low dose PBDE 99: effects on male fertility and neurobehavior in rat offspring.

Authors:  Sergio N Kuriyama; Chris E Talsness; Konstanze Grote; Ibrahim Chahoud
Journal:  Environ Health Perspect       Date:  2005-02       Impact factor: 9.031

8.  Time trends in the outcome of lung cancer management: a study of 9,090 cases diagnosed in the Mersey Region, 1974-86.

Authors:  S W Watkin; G K Hayhurst; J A Green
Journal:  Br J Cancer       Date:  1990-04       Impact factor: 7.640

Review 9.  Evidence for increasing incidence of abnormalities of the human testis: a review.

Authors:  A Giwercman; E Carlsen; N Keiding; N E Skakkebaek
Journal:  Environ Health Perspect       Date:  1993-07       Impact factor: 9.031

10.  Declining semen quality and increasing incidence of testicular cancer: is there a common cause?

Authors:  E Carlsen; A Giwercman; N Keiding; N E Skakkebaek
Journal:  Environ Health Perspect       Date:  1995-10       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.